Suvizumab Antibody is a research-grade biosimilar monoclonal antibody targeting env/Env polyprotein. It is a humanized IgG1, kappa antibody. Reactivity: Human immunodeficiency virus type 1 (HIV-1). Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Envelope glycoprotein gp160 (Envpolyprotein) is a ~97 kDa protein. Oligomerizes in the host endoplasmic reticulum into predominantly trimers. In a second time, gp160 transits in the host Golgi, where glycosylation is completed. The precursor is then proteolytically cleaved in the trans-Golgi and thereby activated by cellular furin or furin-like proteases to produce gp120 and gp41.
Product Name:
Suvizumab Antibody
SKU:
GXBS00501
Size:
100 µg, 1 mg
Antibody Type:
Monoclonal Antibody
Target:
env/Env polyprotein
Isotype:
IgG1, kappa
Host Species:
Human
Reactivity:
Human immunodeficiency virus type 1 (HIV-1)
Applications:
ELISA, FACS, Functional assay, Research in vivo
Expression Host:
Mammalian cells
Synonyms:
KD-247, 914257-21-9
Purity:
>95% purity as determined by SDS-PAGE.
Endotoxin Level:
< 10 EU/mg
Formulation:
0.01M PBS pH 7.4
State of Matter:
Liquid
Regulatory Status:
For research use only. Not suitable for clinical or therapeutic use.
Product Preparation:
Protein A/G purified from cell culture supernatant.
Storage and Handling:
Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
